Amrize (NYSE:AMRZ) Downgraded to “Hold” Rating by Wells Fargo & Company

Wells Fargo & Company lowered shares of Amrize (NYSE:AMRZ) from a strong-buy rating to a hold rating in a research note published on Wednesday, MarketBeat reports. They currently have $44.00 price target on the stock.

A number of other research firms have also recently commented on AMRZ. Royal Bank Of Canada cut Amrize from a “sector perform” rating to an “underperform” rating and cut their price objective for the company from $60.00 to $48.00 in a research report on Monday, August 10th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Zacks Research cut shares of Amrize from a “hold” rating to a “strong sell” rating in a research report on Wednesday, August 19th. Truist Financial reaffirmed a “hold” rating and set a $48.00 price objective (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. Finally, JPMorgan Chase & Co. cut shares of Amrize from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $57.00 to $52.00 in a research note on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $55.50.

Amrize Trading Down 2.3%

AMRZ stock opened at $40.98 on Wednesday. The company’s 50-day simple moving average is $47.76 and its 200-day simple moving average is $52.79. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. Amrize has a 52-week low of $40.92 and a 52-week high of $65.94. The firm has a market cap of $22.66 billion, a P/E ratio of 18.88, a PEG ratio of 1.17 and a beta of 0.04.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The business had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, equities analysts forecast that Amrize will post 2.72 EPS for the current fiscal year.

Amrize Announces Dividend

The firm also recently declared a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize’s payout ratio is presently 20.28%.

Insider Activity at Amrize

In related news, CEO Jan Jenisch bought 4,000 shares of the stock in a transaction dated Wednesday, September 2nd. The shares were acquired at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the acquisition, the chief executive officer directly owned 519,000 shares in the company, valued at approximately $22,057,500. This trade represents a 0.78% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mario Gross bought 3,568 shares of the stock in a transaction dated Tuesday, August 11th. The shares were bought at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the acquisition, the insider owned 38,485 shares in the company, valued at approximately $1,793,401. The trade was a 10.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 48,983 shares of company stock worth $2,158,755 in the last 90 days. 0.54% of the stock is owned by insiders.

Institutional Investors Weigh In On Amrize

Several hedge funds and other institutional investors have recently made changes to their positions in AMRZ. MCF Advisors LLC purchased a new stake in Amrize in the 4th quarter valued at $27,000. Basepoint Wealth LLC purchased a new position in shares of Amrize during the 4th quarter worth $33,000. Itau Unibanco Holding S.A. boosted its position in shares of Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares during the last quarter. US Bancorp DE purchased a new stake in shares of Amrize in the third quarter valued at about $38,000. Finally, Caitong International Asset Management Co. Ltd grew its holdings in shares of Amrize by 141.3% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company’s stock valued at $46,000 after purchasing an additional 496 shares during the period.

About Amrize

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.